Severe Pediatric Asthma Miniseries

Though severe pediatric asthma only represents from 2 to 5% of the children suffering with this condition, it represents a major share of the cost, resource utilization, and morbidity. It is important that allergists have a good gasp of this condition and how it differs from the adult population.

 
PIDD Disparities Miniseries

Patients with Primary Immunodeficiency Diseases (PIDD) are not only susceptible to infection, but they are also at risk for other, non-infectious, complications.  Some of these non-infectious complications can be life-threatening for the patient. This session is intended to discuss how to monitor for these complications, the pathophysiology behind these complications, and the impact new immune therapies have on management of patients with PIDD.

Disparities in Chronic Rhinosinusitis with Nasal Polyps Miniseries

CRSwNP has a significant negative impact on patients’ quality of life, affecting work productivity and sleep, and leading to social and emotional consequences, as well increased economic burden. For underserved populations there is a significant impact on morbidity as well. Minority and low-income groups are less likely to receive proper treatment.

Explore other AllergyTalk episodes